Therapeutic Inhibition of Acid Sensing Ion Channel 1a Recovers Heart Function after Ischemia-Reperfusion Injury

Human induced pluripotent stem cell derived cardiomyocytes as well as ex vivo and in vivo models of ischemia-reperfusion injury were used to test the efficacy of ASIC1a inhibitors as pre- and post-conditioning therapeutic agents.